Device / Technology News

RSS

NIH awards GE Global Research $3.27M to develop highly mobile, less costly MRI systems

Working to expand access of state-of-the-art medical imaging to underdeveloped regions around the world, GE Global Research, the technology development arm for the General Electric Company, has been awarded a four-year, $3.27 million award from National Institutes of Health (NIH) to develop new magnet technology that will make MRI systems less costly and easier to site.

28 Jan 2010

Medicare false claims: Los Angeles DME company owner pleads guilty

The owner and operator of a Los Angeles durable medical equipment (DME) company pleaded guilty today to submitting nearly $1 million in false claims to Medicare, announced Assistant Attorney General Lanny A. Breuer of the Criminal Division and Acting U.S. Attorney George S. Cardona for the Central District of California.

28 Jan 2010

Over 8% of medical devices in circulation are counterfeit: WHO

Counterfeit medical products are becoming an international epidemic. According to the World Health Organization (WHO), more than 8% of the medical devices in circulation are counterfeit. The offending products may be assembled from inferior quality components, or worse yet, from fake parts that could contain toxic materials. In either case the dangers are the same. Counterfeit medical devices pose a significant liability to the manufacturers and a health risk to both the patients and healthcare providers that could result in injury, permanent disability, or even death.

28 Jan 2010

Fuisz Pharma develops novel anti-abuse system for using with abuse prone drugs

Fuisz Pharma today announced the development of a novel anti-abuse system intended for use with abuse prone drugs. This system seeks to address the misuse of addictive drugs with a particular emphasis on opiates and is applicable to all dosage forms.

28 Jan 2010

Inovio Biomedical unveils new clinical-grade, miniaturized electroporation device

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, today unveiled its new clinical-grade, miniaturized electroporation device designed to be an easy-to-use, portable delivery product for DNA vaccines.

28 Jan 2010

Abiomed integrates Opsens’ sensor technology into its Impella catheter

Abiomed, Inc., a leading provider of breakthrough heart support technologies designed for heart recovery, today announced a strategic partnership with Opsens, a leading developer of fiber optic sensors. Through this partnership, Opsens’ breakthrough sensor technology will be integrated into the Impella® catheter to provide robust blood pressure measurements that can be used to enhance Impella’s performance and ease-of-use.

28 Jan 2010

Neomend completes $30M Series D funding round

Neomend, Inc., an innovator in sealant and adhesion-prevention products for the surgical marketplace, announced today it has completed a funding round of $30 million, with Clarus Ventures, LLC investing $17 million.

28 Jan 2010

Electrode devices emerge as potential stimulation treatments for depression

Approximately ten to thirty percent of patients with depression do not respond to drug treatments commonly used for the disorder, and this has spurred a search for alternatives. According to Kalorama Information's report "Electrical and Magnetic Neurostimulation," electrode devices that stimulate nerves have emerged as a solution and there is competition among notable device companies to provide the most effective stimulator.

28 Jan 2010

Researchers develop PEG-POD tool for gene therapy

Researchers at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts have developed a new tool for gene therapy that significantly increases gene delivery to cells in the retina compared to other carriers and DNA alone, according to a study published in the January issue of The Journal of Gene Medicine.

28 Jan 2010

Power-generating rubber films could harness natural body movements

Power-generating rubber films developed by Princeton University engineers could harness natural body movements such as breathing and walking to power pacemakers, mobile phones and other electronic devices.

28 Jan 2010

Top pharmaceutical companies select CRi solutions for drug research and development

BG Medicine launches new, CE-marked galectin-3 test

BG Medicine, Inc., a privately-held developer of biomarker-based in vitro diagnostics, today announced the commercial launch in the European Union of a new, CE-marked test for the measurement of galectin-3 in human plasma or serum. Galectin-3 was first shown by researchers at the University of Maastricht, The Netherlands, to play an integral role in the development and progression of heart failure.

27 Jan 2010

Access Scientific's PICC WAND receives FDA clearance

Access Scientific has received FDA clearance for The PICC WANDTM, which enables clinicians to insert a peelable sheath for PICC or Midline catheter placement using the new Accelerated Seldinger Technique (AST). The PICC WAND is an all-in-one safety introducer that addresses the over-wire vascular access market, valued at more than $1 billion, by providing faster, safer and simpler vascular access.

27 Jan 2010

FDA approves FIRST RESPONSE Early Result Pregnancy Test

Church & Dwight Co., Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared the FIRST RESPONSE® Early Result Pregnancy Test which can determine pregnancy up to six days before the day of a woman's missed period

27 Jan 2010

FDA clears Notal Vision's ForeseeHome AMD Monitor

Notal Vision's ForeseeHome™ AMD Monitor has received Section 510 (k) clearance from the U.S. Food and Drug Administration (FDA).

27 Jan 2010

Web-based records worried patients, prompting more neutral language

Kaiser Permanente's experience while providing digital records to patients highlights the potential for miscommunications -- and sometimes needless alarm, The Huffington Post Investigative Fund reports. The health care company gave patients access to the same online lab reports that went to doctors and they included warning messages, such as a capital "H" to indicate above average results. That worried enough patients that the managed-care giant changed its format.

27 Jan 2010

VentriPoint Diagnostics to present abstract on VMS clinical validation study

VentriPoint Diagnostics Ltd. today announced the abstract of a clinical validation study of the second application of the VentriPoint Medical System (VMS) will be presented at the American College of Cardiology's 59th Annual Scientific Session, March 14 to 16 in Atlanta, Georgia. The study demonstrates the accuracy of the method used by the VentriPoint Medical System (VMS) to generate critical heart measurements in three dimensions from two-dimensional ultrasound images with significantly greater speed and accuracy and at considerably lesser cost than is otherwise possible.

27 Jan 2010

TE can be accurately performed in majority of NAFLD patients to exclude advanced fibrosis

Researchers from France and Hong Kong determined that transient elastography (TE), a noninvasive, ultrasonic imaging modality, can be accurately performed in the majority of patients with nonalcoholic fatty liver disease (NAFLD) to exclude advanced fibrosis. Full findings of this study, funded by the Chinese University of Hong Kong, appear in the February issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.

27 Jan 2010

TeleTracking Technologies' Bed Management Suite selected as leading patient flow solution

For the third straight year TeleTracking's Bed Management Suite™, with the trend-setting electronic bedboard® , was selected "Category Leader – Patient Flow" (formerly Bed Management) by healthcare providers who use automated patient flow solutions, according to healthcare market researcher KLAS.

27 Jan 2010

Hypothermic machine perfusion outperforms standard cold-storage liver preservation

Preserving organs on ice prior to transplantation, an approach known as cold storage or CS, has been the standard practice in liver transplant for 20 years. Now there is new evidence that a technique called hypothermic machine perfusion (HMP) may offer an improvement, according to the first-ever study comparing the impact of the two techniques on transplant outcomes.

27 Jan 2010